reports
Snap Inc: 1 director
A director at Snap Inc sold/gave away 1,302,084 shares at 0.000USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Sunrun’s Distributed Power Plant Quadruples in Size to 75,000 Solar-Po...
Sunrun’s Distributed Power Plant Quadruples in Size to 75,000 Solar-Powered Batteries to Support California’s Grid Sunrun customers create one of the nation’s largest solar-powered battery resources to bolster grid reliability and help prevent blackouts by networking together tens of thousands of distributed home storage systems SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation's leading provider of clean energy as a subscription service, announced today that its CalReady power plant has more than quadrupled in size as the summer heat begins to stress the ...
- Dan Salmon
US Internet: What we know (and don’t know) about China/de minimis adve...
On Monday, we analyzed GOOGL and META’s potential exposure to China-based advertisers HERE, and discussed META’s exposure more HERE. Last night, SNAP cited weakness from advertisers impacted by changes to the de mimimus exemption as one example of the macro uncertainty that led it to pull 2Q25 guidance (see HERE for full takeaways). Led by Temu and Shein, there is likely high overlap between China-based retailers and those impacted by de minimis exemption changes.
Sunrun Installs Solar Projects at Three Affordable Apartment Communiti...
Sunrun Installs Solar Projects at Three Affordable Apartment Communities in Southern California, Providing Energy Bill Savings to 800 Renters Officials join Republican U.S. Representative Young Kim for ribbon cutting event to celebrate new solar projects at low-income apartment communities in Orange County that provide immediate utility bill savings to hundreds of working families SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, today announced three new solar installations at affordable apar...
Esperion to Participate in The Citizens Life Sciences Conference
Esperion to Participate in The Citizens Life Sciences Conference ANN ARBOR, Mich., April 25, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted Citizens Life Sciences Conference on May 8, 2025, at 12:30 p.m. ET. The live webcast can be accessed on the investor and media section of the Esperion . Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days. Esperion TherapeuticsEsperion Therapeutics, Inc. ...
Esperion Unveils Promising Research Supporting Lead Development Candid...
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025 – Expands Development Portfolio with Introduction of a Novel Program Targeting PSC – – Confirms Highly Specific Allosteric ACLY Inhibitor Shown to Reduce Liver Injury, Inflammation and Fibrosis Across Multiple PSC-Relevant Pre-Clinical Models – – Demonstrates Internal R&D Capabilities with Wholly Owned, Next-Generation Candidates Targeting Liver and Kidney Disease – – Esperion to Webcast R&D Day Event Today at 9:00 a.m. ET – ANN ARBOR, Mich., April 24, 202...
- Dan Salmon
Esperion to Report First Quarter 2025 Financial Results on May 6
Esperion to Report First Quarter 2025 Financial Results on May 6 ANN ARBOR, Mich., April 23, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion . Access to the webcast replay will be available approximately two hours after completion of the call and will b...
Sunrun Announces Date for First Quarter 2025 Earnings Report
Sunrun Announces Date for First Quarter 2025 Earnings Report Earnings Release and Conference Call Scheduled for May 7, 2025 SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN) today announced that it will issue its first quarter 2025 earnings report after the market closes on Wednesday, May 7, 2025. A conference call has been scheduled to discuss these earnings results at 1:30 p.m. Pacific Time. The conference call can be accessed live via the Sunrun Investor Relations website at or over the phone by dialing (877) 407-5989 (toll-free) or (201) 689-8434 (toll). An ...
Esperion to Host R&D Day to Highlight Cardiometabolic Pipeline Innovat...
Esperion to Host R&D Day to Highlight Cardiometabolic Pipeline Innovation and Next-Generation Therapeutics on April 24, 2025 Highlighting Novel Insights into ATP Citrate Lyase (ACLY) Biology and its Therapeutic Potential in Multiple Life-Threatening Diseases ANN ARBOR, Mich., April 10, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it will host an in-person R&D Day for analysts and investors on April 24, 2025, beginning at 9:00 a.m. ET in New York City. This event will feature presentations from company leadership and key opinion leaders to provide a deep dive int...
Esperion Appoints Robert E. Hoffman to Board of Directors
Esperion Appoints Robert E. Hoffman to Board of Directors - Veteran Industry Executive Brings Decades of Financial and Leadership Experience - ANN ARBOR, Mich., April 01, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Robert E. Hoffman as an independent director, effective immediately, and he will also serve as Chairperson of the Audit Committee effective May 29, 2025. In addition, the Company announced that Nicole Vitullo and Antonio M. Gotto, Jr., M.D., D. Phil. will step down from the board of directors, effective June 1, 2025. “We are pleased to ...
Esperion to Participate in 24th Annual Needham Virtual Healthcare Conf...
Esperion to Participate in 24th Annual Needham Virtual Healthcare Conference ANN ARBOR, Mich., March 24, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 24th Annual Needham Virtual Healthcare Conference on April 7, 2025, at 8:45 a.m. ET. The live webcast can be accessed on the investor and media section of the Esperion . Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days. Esperion Therapeutic...
Sunrun and PG&E Harness Home Storage and Solar to Alleviate Local Grid...
Sunrun and PG&E Harness Home Storage and Solar to Alleviate Local Grid Constraints The first-of-its-kind program with California's largest utility will dispatch home battery power to enhance local grid reliability SAN FRANCISCO, March 24, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, today announced a new innovative partnership with Pacific Gas and Electric Company (PG&E). The collaboration will utilize hundreds of Sunrun solar-plus-storage customer homes to deliver targeted load relief to neighborhoods identified...
Esperion Aligns with U.S. Food and Drug Administration to Initiate Pha...
Esperion Aligns with U.S. Food and Drug Administration to Initiate Phase 3 Clinical Trials of Bempedoic Acid in Pediatric Heterozygous and Homozygous Familial Hypercholesterolemia – Confirms Sufficient Data to Complete Phase 2 Clinical Study Enrollment and Advance to Phase 3 Studies in Both Heterozygous and Homozygous Familial Hypercholesterolemia – – Establishes Pediatric Path Forward to Start and Complete Phase 3 Trial and Secure Additional Six-Month Patent Extension Through June 2031 – ANN ARBOR, Mich., March 20, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that f...
Sunrun Earns Best Company’s 2025 Platinum Solar Award and Preferred Pa...
Sunrun Earns Best Company’s 2025 Platinum Solar Award and Preferred Partner Award Sunrun honored for providing Americans across the country an unparalleled experience with industry-leading solar and storage products and service SAN FRANCISCO, March 05, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), America’s leading provider of clean energy as a subscription service, has been awarded the 2025 Platinum Solar Award and the exclusive Preferred Partner Award by BestCompany.com, a leading reviews platform that empowers consumers to make confident purchase decisions. These awards recognize Su...
Sunrun Inc: 6 directors
Five Directors at Sunrun Inc sold after exercising options 18,561 shares at between 6.358USD and 6.567USD. The significance rating of the trade was 19/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's ...
Esperion Reports Fourth Quarter and Full Year 2024 Financial Results
Esperion Reports Fourth Quarter and Full Year 2024 Financial Results – FY24 Total Revenue Grew 186% Y/Y to $332.3 Million; FY24 U.S. Net Product Revenue Grew 48% Y/Y to $115.7 Million – –Q4 Total Revenue Grew 114% Y/Y to $69.1 Million; Q4 U.S. Net Product Revenue Grew 52% Y/Y to $31.6 Million – – Q4 Retail Prescription Equivalents Grew 45% Y/Y and 12% Q/Q – – Focused On Three Pillars for Building a Blockbuster Company: Continued Revenue Growth, Reaching Operating Profitability, and Portfolio Expansion/Pipeline Advancement – – Announces Development of Trip...
- Jonathan Moreland
WWW WOLVERINE WORLD WIDE INC.
TRS TRIMAS CORPORATION
STAA STAAR SURGICAL CO.
SIGI SELECTIVE INSURANCE GROUP INC.
RUN SUNRUN INC.
PBF PBF ENERGY INC. CLASS A
OSUR ORASURE TECHNOLOGIES INC.
LTRX LANTRONIX INC.
KTOS KRATOS DEFENSE & SECURITY SOLUTIONS INC.
GERN GERON CORP.
FSS FEDERAL SIGNAL CORPORATION
APLE APPLE HOSPITALITY REIT INC
DGICA DONEGAL GROUP INC. CL A
KYN KAYNE ANDERSON MLP INVESTMENT CO.
FLWS 1-800-FLOWERS.COM CL A
JELD JELD-WEN HOLDING INC.
FTDR FRONTDOOR INC.
AMCR AMCOR PLC
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
GO GROCERY OUTLET HOLDING
PDSB PDS BIOTECHNOLOGY CORPORATION
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
UTZ UTZ BRANDS INC (A)
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
FLYW FLYWIRE CORP
ECAT BLACKROCK ESG CAP ALLOCATION TR
BNTC BENITEC BIOPHARMA INC
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedo...
Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia – Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales – ANN ARBOR, Mich., March 03, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia and New Zealan...
Sunrun Reports Fourth Quarter and Full Year 2024 Financial Results
Sunrun Reports Fourth Quarter and Full Year 2024 Financial Results Cash Generation of $34 million in Q4 after safe harbor equipment purchases, third consecutive quarter of positive Cash Generation Paid down $132 million of recourse debt in Q4 with excess cash Cash Generation guidance of $200 million to $500 million in 2025 Cash Generation guidance of $40 to $50 million in Q1 Net Earning Assets increased to $6.8 billion, including $947 million of Total Cash Storage Capacity Installed of 392 Megawatt hours in Q4, exceeding high-end of guidance range and representing 78% year-over-year gr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.